Ana Hilde, M.P.H., received a tuition waiver from the NIDA International Program to attend the Summer Institute on Alcohol, Drugs and Addiction in the Netherlands earlier this year.
The Summer Institute, a joint initiative of ZonMw and the University of Amsterdam Graduate School of Social Sciences, is a 2-week, intensive multidisciplinary program offering graduate-level and continuing professional development training in addiction, while promoting opportunities for international networking.
D. Dwayne Simpson, Ph.D., emeritus director of the Institute of Behavioral Research, Texas Christian University (TCU), utilized his U.S. Distinguished International Scientist Award (USDISCA) to continue the collaborative work he began in 2005 to put in place an infrastructure for several regional initiatives and resources to target substance misuse in the United Kingdom (UK).
Sixteen NIDA-supported researchers presented their research earlier this fall in New Orleans, Louisiana, at the National Hispanic Science Network (NHSN) International Conference. This year’s meeting focused on transdisciplinary approaches to current research agendas and the future of addiction research and treatment.
Drs. Zabransky (left) and Bém at a reception at the mayor’s residence.
Two former Hubert H. Humphrey Fellows, Pavel Bém, M.D., and Tomas Zabransky, M.D., Ph.D., were organizers of a meeting on urban drug policy in Prague that led to the adoption of the Prague Declaration, a set of seven principles of effective drug policies and a call for greater participation of urban leaders in forming drug policies.
Drug abuse and HIV/AIDS researchers across the globe are taking advantage of local meetings to bridge the regional gap that often hinders the exchange of research ideas and the development of constructive collaborations. Meetings were held recently in Malaysia, Norway, and Ukraine
Kenneth W. Griffin, Ph.D., M.P.H., Weill Cornell Medical College, and Irina Pervova, Ph.D., St. Petersburg State University (SPSU), used Dr. Griffin’s U.S. Distinguished International Scientist Collaboration Award (USDISCA) to conduct key informant interviews and focus groups on the epidemiology, etiology, and prevention activities regarding adolescent substance use in St.
Perrine Roux, Pharm.D., Ph.D., French National Institute of Health and Medical Research (Inserm), has been selected as a NIDA INVEST Drug Abuse Research Fellow. She will work with Sandra D. Comer, Ph.D., Columbia University, to better define the concept of nonadherence to opioid maintenance treatment with buprenorphine/naloxone and to validate a tool to measure nonadherence using a self-administered questionnaire.